Name: UMIN ID:
Unique ID issued by UMIN | UMIN000039048 |
---|---|
Receipt number | R000044525 |
Scientific Title | Phase II study of VAC1.2(vincristine, actinomycin-D, cyclophosphamide) therapy for patients with newly diagnosed low-risk subset A rhabdomyosarcoma. |
Date of disclosure of the study information | 2020/01/10 |
Last modified on | 2020/01/03 10:50:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/01/03 20:01:03 |